Antigen Anti Articles & Analysis
8 news found
Creative Diagnostics now offers a series of reagent solutions for global scientists studying the monkeypox virus, including various antigens and antibodies, such as Mouse Anti-MPXV M1R Monoclonal Antibody for ELISA/Neut, and Monkeypox Virus A35R protein, recombinant from E. coli. More Monkeypox Virus Antigens and Antibodies are available at ...
In the follow-up analysis, participants in PROTECT who received VBI’s 3-antigen HBV vaccine had 5.5-fold higher mean anti-HBs titers (GMC: 1382.9 mIU/mL vs. 251.4 mIU/mL) and a higher seroprotection rate (SPR: 88.1% vs. 72.4%) compared to those who received Engerix-B. Additionally, 72.9% of participants who received VBI’s 3-antigen ...
(Nasdaq: NEXI), a clinical-stage biotechnology company developing a novel approach to immunotherapy designed to orchestrate a targeted immune response by directing the function of antigen-specific T cells, today announced a preclinical research collaboration with Columbia University Irving Medical Center’s (CUIMC) Herbert Irving Comprehensive Cancer Center (HICCC). ...
Combining Zephyr’s proprietary artificial intelligence (AI) and algorithmic technology with NexImmune’s Artificial Immune Modulation (AIM) nanoparticle technology, the collaboration will seek to identify and validate optimal antigens and antigen cocktails for the development of potential new therapeutics in solid and hematological cancers. Under the ...
The collaboration is centered around NexImmune’s artificial antigen presenting cells' (aAPCs) ability to expand neoantigen-specific CD8+ T cells in apheresis material provided by melanoma patients. ...
So far, we offered Rapid tests for anti-bodies and antigens. Our goal is to bring this revolutionary solution to the market, so we are currently immersing ourselves in pilot trial runs with the SpectraLIT™ product which guarantees reliable COVID-19 results in seconds using patient’s swab or mouthwash sample”. ...
By “rewiring” innate antiviral defense mechanisms, some of our molecules also have the potential to improve the expression of nucleic acid-encoded COVID-19 antigens as well as anti-COVID-19 immunity. Virica and its founders have a history of collaboration with vaccine manufacturers and pharmaceutical companies. ...
Dako, an Agilent Technologies company and worldwide provider of cancer diagnostic solutions, today announced the addition of two new antibodies, Anti-CK 8/18 and Anti-TdT, to the Dako portfolio of high-quality reagents, instruments and software. Anti-CK 8/18 is the first rabbit monoclonal antibody cocktail for cytokeratin 8/18 (CK 8/18) ...